PRDS — Pardes Biosciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareAdventurousSmall Cap
- $133.95m
- -$19.25m
Annual cashflow statement for Pardes Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -13 | -38.5 | -96.6 |
| Non-Cash Items | 7.69 | 1.22 | 9.5 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | 1.76 | 0.379 | 15.2 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Other Operating Cash Flow | |||
| Cash from Operating Activities | -3.56 | -36.9 | -72 |
| Other Investing Cash Flow Items | — | — | -137 |
| Sale/Maturity of Investment | |||
| Purchase of Investments | |||
| Cash from Investing Activities | — | — | -137 |
| Financing Cash Flow Items | 6.96 | 58.7 | -0.397 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 6.96 | 302 | -0.397 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 3.41 | 265 | -209 |